15 SM/J mouse hybridoma antibodies that show antithymocyte autoantibody (ATA) activity by immunofluorescence staining were studied. Half of these antibodies react with determinants whose expression is associated with Thy-1, as shown by blocking experiments with antiThy-1 and loss of reactivity with Thy-1 -mutant cell lines . The Thy-1 dependence of three of these ATA is further confirmed by their reexpression on a Thy-1 gene transfectant . However, the remaining antibodies exhibited binding that showed little or no dependence on Thy-1. Furthermore, we find that most ATA derives from the Ly-1 B subpopulation, as demonstrated by lipopolisaccharideinduced ATA secretion in vitro and by comparison of ATA hybridoma frequencies. V region gene sequence data of 14 monoclonal ATA from Ly-1 B cell-derived hybridomas reveal the utilization of nine V genes belonging to four different V H families (J558, 3609, Q52, and Vgam3.8) . While we find that two of these hybridomas arose from a clonal expansion, we also find four examples of a 3609 family V gene utilized in clonally independent lines showing similar specificity. Yet another example of identical V gene usage by clonally unrelated cells is found in two J558 ATA of a distinct fine specificity. These data suggest that the enrichment of ATA B cells in the Ly-1 B subset is primarily due to repeated independent recruitment of B cells by antigen resulting in the expression of a restricted set of VH genes.
15 SM/J mouse hybridoma antibodies that show antithymocyte autoantibody (ATA) activity by immunofluorescence staining were studied. Half of these antibodies react with determinants whose expression is associated with Thy-1, as shown by blocking experiments with antiThy-1 and loss of reactivity with Thy-1 -mutant cell lines . The Thy-1 dependence of three of these ATA is further confirmed by their reexpression on a Thy-1 gene transfectant . However, the remaining antibodies exhibited binding that showed little or no dependence on Thy-1. Furthermore, we find that most ATA derives from the Ly-1 B subpopulation, as demonstrated by lipopolisaccharideinduced ATA secretion in vitro and by comparison of ATA hybridoma frequencies. V region gene sequence data of 14 monoclonal ATA from Ly-1 B cell-derived hybridomas reveal the utilization of nine V genes belonging to four different V H families (J558, 3609, Q52, and Vgam3.8) .
While we find that two of these hybridomas arose from a clonal expansion, we also find four examples of a 3609 family V gene utilized in clonally independent lines showing similar specificity. Yet another example of identical V gene usage by clonally unrelated cells is found in two J558 ATA of a distinct fine specificity. These data suggest that the enrichment of ATA B cells in the Ly-1 B subset is primarily due to repeated independent recruitment of B cells by antigen resulting in the expression of a restricted set of VH genes.
T he existence of spontaneously occurring autoantibodies has been recognized for many years (1) (2) (3) (4) (5) (6) (7) . Since the serum levels of these antibodies do not show etiologic relevance to disease (8) , the pathologic significance of such "natural" autoantibodies is not clear. One of these natural autoantibodies, antibody to a cryptic determinant on erythrocytes (anti-bromelain-treated mouse RBC [anti-BrMRBC]'), is largely contributed by a unique B cell subset, Ly-1 B (9, 10) . Ly-1 B comprises a minor (1-2%) subset in the normal secondary lymphoid organ (spleen) or PBL, whereas it is uniquely enriched in mouse peritoneal cavity (PerC) (11) (12) (13) . Ly-1 (CD5) expression has also been found on late-developing IgM+ B lymphomas (14) . From our previous data with cell transfer experiments, we suggest that Ly-1 B constitutes a distinct B cell lineage ; most Ly-1 B cells present in adult mice are the progeny of cells generated from an early B cell source (fetal liver) (15) , are maintained by self-renewal, and poses the potential for disregulated growth later in life (13, 14, (16) (17) (18) (19) .
Although the biological role ofLy-1 B in the immune system is not clearly understood, this subset appears to be phylogenically conserved since it is found in both mice and humans (13, 20) . One fundamental question relating to the biological function of Ly-1 B is the extent of its contribution to autoantibody secretion and the mechanism to allow such expression . Although enrichment of autoantibody specificities in this B cell subset has been suggested previously (11, 13) , explicit determination of the antibody specificities (and V genes) characterizing Ly-1 B would provide help in answering these questions . In murine Ly-1 B, the anti-BrMRBC specificity encoded by V11 (together with V,,9) provided the first example demonstrating such bias (9, 10, 21) . These V genes have also been found recurrently (in an unmutated form) in the B lymphomas mentioned above (19) .
We report here studies on the cellular origin, specificity, and primary structure of a group of natural antithymocyte autoantibodies (ATA). ATA secretion occurs spontaneously in normal animals, and these antibodies bind to intact thymocytes (3, 4, 7, 8) . Although high levels of ATA have been found in animals with autoimmune disease (e.g., NZB mice) (4), they have also been detected at high levels in some strains of mice without apparent disorders (SM/J mice) (8) . That Ly-1 B might be the source of ATA was foreshadowed by the fact that both NZB and SM/J mice have elevated levels of Ly-1 B cells (10, 11, 13, 22) and increased frequencies of anti-BrMRBC and ATA in their sera (4, 5, 8) . Furthermore, as we previously reported, Ly-1 B in NZB mice are largely responsible for the spontaneous secretion of IgM in vitro, including ATA (9) . However, whether this was due to the unique predisposition of NZB Ly-1 B to secrete Ig spontaneously in vitro, or instead to a higher frequency of ATA specific B cells in the Ly-1 B population, remained to be determined.
We now show that ATA-specific B cells are enriched among Ly-1 B cells. To attempt to understand the mechanism resulting in such a bias of specificity in Ly-1 B, we examined SM/J Ly-1 B-derived antithymocyte hybridomas, defining their fine antigen specificity and associated V gene usage. Earlier work had suggested that the major antigens in ATA show a common tissue distribution in most cases (8) , probably including determinant(s) on the Thy-1 molecule (4, (23) (24) (25) (26) . However, heterogeneity in ATA determinants either related or unrelated to Thy-1 has also been reported (4, 8, (27) (28) (29) (30) . As we report here, natural ATA are composed of antibodies specific for diverse determinants and encoded by various V genes, with many of these antibodies recognizing antigens (probably of carbohydrate nature) present on the Thy-1 glycoprotein . Furthermore, we found that similar specificities recur between clonally unrelated ATA hybridomas, which exhibit repeated usage of nearly identical VH genes. The implications of this finding are discussed.
Materials and Methods
Animals. SM/J mice were purchased from The Jackson Laboratory (Bar Harbor, ME) . BALB/cAnN, AL/N and AKR/J mice, and F344N rats were bred and maintained in the Institute for Cancer Research animal facility. 2-4-mo-old female animals were used in all experiments.
Immunofluorescence Staining and Sorting. Preparation ofcells, reagents for immunofluorescence staining, cell sorting using FACS (FACStar plus; Becton Dickinson Immunocytometry Systems, Mountain View, CA), and data analysis were all described previously (10, 31) .
Induction ofATA Secretion In Vitro. Spleen cells from SM/J and BALB/c mice and cells from the BALB/c PerC were stained with fluorescein-anti-IgM (331.12) and allophycocyanin (APC)-anti-Ly-1 (53-7). 2-4-mo-old SM/J mice and BALB/c mice consistently show 4-7% and 1-2% Ly-1 B (Ly-1*IgM+) cells in spleen, respectively (10, 11, 13) . Ly-1 B cells represent 10-30% of total cells in BALB/c PerC (13) . Ly-1 -B cells are identified as Ly-1 -IgM* cells in spleen. Sorting of spleen cells lacking Ly-1 B (Ly-1 B depleted) or Ly-1 -B (Ly-1 -B depleted) was carried out by using the FACS sort gates set to cancel the selected population. All cell cultures were initiated at 106 cells/ml in RPMI 1640 + 10% FCS + 5 p,M 2-ME with or without LPS (10 ttg/ml) .
Production, Screening, and Cloning of ATA Hybridomas. ATA hybridoma clones were produced and selected at the same time as the anti-BrMRBC hybridomas reported previously (10) . Briefly, after staining of spleen cells pooled from five SM/J mice, Ly-1 B and Ly-1-(IgD++) B cells were isolated by sorting, cultured for 2 d in the presence ofLPS, and then hybridized with aHATsensitive
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Antithymocyte Autoantibody MPC11 myeloma cell line (,y2b,K). Six 96-well plates (estimated three to four clones/well) (10) from the Ly-1 B hybridization were all positive for IgM secretion, and their supernatants were screened for ATA activity by immunofluorescence staining on SM/J mouse thymocytes, as revealed by APC-anti-IgM (331.12). Simultaneously, these supernatants were tested for anti-BrMRBC, anti-mouse RBC (MRBC), anti-splenic B cell, and anti-bone marrow cell activities by staining and for anti-ssDNA and anti-mouse IgG activities by an ELISA. Most ATApositive wells did not show crossreactivity in these assays, with the exception of one well (showing binding to ssDNA, cloned as 1-6D7) . Ly-1 -B cell hybridomas were screened only for ATA activity. ATA-positive wells were cloned by cell sorter immediately after the screening. Analysis ofMonoclonal ATA Reactivity to Various Cell Types. Hybridomas were maintained in Opti-MEM (Gibco Laboratories, Grand Island, NY) + 4% FCS + 2-ME. Ascites was produced in CB.17 scid mice, and 25 ul of 1/100 diluted ascites for 5 x 105 cells was used for immunofluorescence staining (revealed by APCanti-IgM; 331.12). For thymocyte, splenic T cell and bone marrow staining, BALB/c mice (which show comparable staining with SM/J mice) were normally used, except for MG10 (negative with BALB/c), where AKR mice were used. For splenic non-T cellstaining, AL/N mice (negative with 331.12) were used to avoid B cell staining by second-step anti-IgM antibody. AL/N thymocytes were stained by all ATA used here.
AntiThy-1 Blocking. To examine the blocking of ATA staining by antiThy-1 antibody, 10 Wg of rat antiThy-1 .2 (30-1112) or rat antiThy-1.1 (T11D7e2 ; provided by Dr. M. Dailey, University of Iowa) antibody was used simultaneously with limiting dilutions (1/100-1/3,000) ofATA for BALB/c and AKR thymocyte staining, respectively. Anti-CD45 (30F11) and anti-CD5 (53-7) antibodies were used as negative controls .
Sodium mperiodate Treatment. Thymocytes were fixed with 3% (wt/vol) paraformaldehyde in PBS, washed, and treated with or without 0.08 M sodium m-periodate in 0.05 M sodium acetate buffer, pH 5 .5, at 37°C for 2 h, as described elsewhere (32, 33) .
T Lymphoma Cell Lines and Their Mutants. BW5147(Thy-1 -a) and BW5147(Thy-1 -e) are Thy-1 -mutant cell lines derived from BW5147(Thy-1+) wild type (34, 35) . Both class A and E mutants are defective in the anchoring of membrane Thy-1 glycoproteins via the phosphatidylinositol-containing glycolipid anchor ofThy-1 (36) , and the class E mutant has a mutation in the gene coding for GDP-mannose :dolichol-P-mannosyltransferase, which presumably affects the biosynthesis of glycolipid tails in addition to the biosynthesis ofWinked high-mannose oligosaccharides (36, 37) . The AKR1(Thy-1 -d) cell line is a class D mutant from AKR1 (Thy-1+) wild type. This mutant has a deletion of the 5' portion of the Thy-1 gene including the first two alternatively used exons and promoters and a portion of the second intron (38) . TFX351 is a Thy-1 .1+ transfectant of AKR1(Thy-1 -d). An 8.1-kb EcoRI genomic fragment containing the Thy-1 .1 gene (39) was ligated into the vector pSV2gpt (40) in an inverse orientation to the SV40 enhancer. This construct was introduced into AKR1 (Thy-1 -d) by electroporation .
Sequence Determinations ofIgH Variable Regions ofRNA . Poly-(A)+ mRNA was isolated from hybridomas and sequenced by h primer extension, as described previously (10), in most cases. The 3609 sequences showed several strong stops in sequencing by primer extension, so an alternate method using PCR was used for these clones . A first-strand cDNA was synthesized from mRNA with reverse transcriptase, then oligos complementary to the 5' region of FW1(5'-TTACTCTAAAAGAGTCTGGCCCTGGG-3') of the 3609 gene and to the 5' region of the CIA sequence (5'-GGCTCT Ly-1 B Cells Are Responsible forATA Secretion. Spleen cells from mice of the nonautoimmune SM/J strain, unlike most mouse strains, secrete IgM ATA detectable by immunofluorescence staining after stimulation with LPS in culture ( Fig. 1  a) . We found that this ATA secretion from SM/J spleen was completely eliminated after depletion of Ly-1 B cells (comprising 5% of spleen cells; reference 10) without a significant decrease in the total IgM produced (Fig. 1 a) . Depletion of Ly-1 -B cells (the majority of B cells in spleen) did not affect ATA secretion (Fig. 1 a) whereas, as expected, total IgM and B cell proliferation (data not shown) were greatly reduced . 10 100
Ly-1 B depleted
CGCAGGAGACGAGGG-3') were added, and finally the mixture was amplified in a standard PCR reaction. After gel purification, the DNA was then sequenced in a double-stranded sequencing procedure (41) using the original PCR primers. Mouse p, and other oligonucleotide primers used for sequencing and as PCR primers were synthesized using phosphotriester chemistry by an oligonucleotide synthesizer (Applied Biosystems, Inc., Foster City, CA) without further purification . Sequences were analyzed with the Wisconsin Sequence Package running on a VAX computer (Digital Equipment Corp., Burlington, MA) as described previously (10) . Thus, the presence ofLy-1 B is required for LPS-induced ATA secretion from SM/J mouse spleen cells . We found that Ly-1 B cells are exclusively responsible for ATA secretion, not only in SM/J mice but also in BALB/c mice. Purified Ly-1 B and Ly-1 -B cells from SM/J spleen, or BALB/c peritoneal cavity Ly-1 B cells and Ly-1 -B cells from BALB/c spleen were used for comparing levels of ATA secretion in LPS culture. As Fig. 1 , b and c show, both supernatants from Ly-1 B cells contain ATA activity. The ATA binding activity determined by immunofluorescence staining intensity correlates with ATA levels in the secreted IgM, as shown in Fig. 2 . Although Ly-1 B cell cultures initially secrete more IgM than Ly-1 -B cell cultures, no antithymocyte activity was ever detected in the supernatant from Ly-1 -(conventional) B cells during 7 d of LPS culture, even after comparable levels of IgM were attained (Fig. 2) . The possibility that ATA secretion from Ly-1 -B cells in the LPS culture system might be dependent on T cells (or some other cell type) could be excluded since Ly-1 B-depleted SM/J spleen cells, which include all non-B cells in spleen, did not show ATA activity during the course of culture (similar to results using purified B cell populations) . Thus, these data strongly suggest that a distinct B cell subset, Ly-1 B, is responsible IgM concentrations used for staining (on the abscissa) are proportional to the secreted antibody levels; (a) Ly-1 B d3 (4 .0 tug/ml) and d7 (9.0 hg/ml), Ly-1 -B d3 (3.6 /4g/ml) and d7 (5 .6 Ftg/ml); (b) Ly-1 B d3 (20.5 Ecg/ml) and d7 (43.0 lug/ml), and Ly-1 -B d3 (1.0 Rg/ml) and d7 (18.0 tag/ml). Data of 1:10 (a) and 1:3 (b) diluted supernatants from Ly-1 B cell cultures were also included in plots. Saturation of ATA binding was observed at >10 Ag/ml of IgM in the Ly-1 B supernatant.
for natural ATA secretion in most strains, and further, that the increased population of Ly-1 B cells in SM/J mice is responsible for the characteristically high levels of serum ATA found in this mouse strain.
The Specificity ofATA Hybridomas Are Diverse. ATA from Ly-1 B cells was characterized further by establishing hybridomas. Hybridomas made from Ly-1 B and conventional Ly-1 -(IgD2+) B cells sorted from a pool of SM/J mouse spleen were plated in limiting dilution to assess the frequency of clone/well, as described previously (10) . Results from the initial screening of 576 IgM secreting wells from both Ly-1 B and Ly-1 -B cell fusions showed that the frequency of clones with antithymocyte binding reactivity from Ly-1 B was higher, 1% (23/1,728-2,304; three to four clones/well; reference 10) compared with 0.1% (3/2,880; five clones/well) from Ly-1 -B cells, consistent with results of the ATA secretion assay described above. From these positive wells, we isolated 17 antithymocyte Ly-1 B hybridoma clones and one Ly-1 -B hybridoma clone . Two ATA Ly-1 B hybridoma clones were obtained in a separate cell fusion experiment (10). scribed above led us to consider the involvement of carbohydrate structures as the antigenic determinants, since carbohydrate components ofcell surface molecules are often altered during cell development or differentiation, and can be expressed in a strain-or species-specific manner (42, 43) . Supporting this prediction, the reactivity of 11 of these autoantibodies was sensitive to prior treatment of target cells with sodium metaperiodate, which preferentially oxidizes terminal sialic acid groups (32) ( Table 2) . Thy-1 is a major glycoprotein of the thymus, so the ability ofantiThy-1 antibody to block ATA binding was investigated by immunofluorescence staining (Table 2 and Fig. 3 ). The binding of the eight group I ATA antibodies was nearly completely blocked by prior or simultaneous incubation of thymocytes with antiThy-l antibody, while the binding of two ATA antibodies (group II) was partially blocked. Blocking by antiThy-1.1 or antiThy-1 .2 antibodies was specific to the appropriate Thy-1 allele, and other antibodies (anti-CD45, anti-CD5) that react with determinants present on the majority of thymocytes did not block (data not shown) . This result suggests that the determinant detected by these antibodies either resides on the Thy-1 glycoprotein or on a molecule that is present in close proximity to the Thy-1 glycoprotein .
Stained with anti-Thyl.l . t No staining after treatment without periodate.
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To more directly study the relationship of the determinants defined by the ATA antibodies ofgroups I and II to the Thy-1 molecule, the staining of these antibodies on a panel of cell lines was examined. BW5147 is a Thy-1+ lymphoma derived from AKR/J (Thy-1 .1) mice, while BW5147 (Thy-1 -a) and BW5147 (Thy-1-e) are Thy-1 -mutants with defects in genes affecting post-translational steps necessary for cell surface expression of the Thy-1 glycoprotein (and other cell surface molecules anchored in the cell membrane through a glycophospholipid moiety) (34) (35) (36) (37) . AKRl is also a Thy-1+ lymphoma derived from AKR/J mice, while AKRl ( Thy-1 -d) is a Thy-1 -mutant that has undergone deletion of a portion of the Thy-1 structural gene (38) . TFX351 is a Thy-l+ derivative of AKRl (Thy-1 -d) in which a normal copy ofthe Thy-1.1 structural gene was introduced by transfection .
The staining results of ATA on this panel of cell lines are summarized in Table 2 , and examples of FACS profiles obtained are shown in Fig. 3 . The three ATA of group I show an absolute concordance with expression of the Thy-l glycoprotein . Therefore, it seems highly likely that these ATA recognize one or more determinants present on the Thy-1 glycoprotein. The rest of group I ATA stain neither the wild-type AKRI cell line nor transfectant TFX351 . However, these antibodies do show moderate to weak staining on the wildtype BW5147 cell line but do not stain either BW5147 mutant. Antibodies of group II show binding, although weakly with a somewhat brighter tail in the FACS profile, to the class D mutant derived from AKRL Therefore, it is unlikely that the determinant recognized by this antibody resides solely on the Thy-1 glycoprotein . As with the group I antibodies, group II ATA stain the wild-type BW5147 cell lines, but neither Thy-1 -mutant derived from this cell line.
Consistent with the failure of antiThy-1 antibodies to block ATA of groups III-VI, ATA of these groups either failed to stain any cell line, whether Thy-1+ or not (groups IV-VI), or stained all cells, whether wild-type or mutant (group III). The determinants for group V antibodies (1-3G11 and 1-3H5) are present at high levels on mature T cells where their expression is uncorrelated with Thy-1 . Recent studies show that group V antibodies (1-3G11 and 1-3H5) react with carbohydrate determinant present on a glycolipid (ganghoside), which is probably the predominant source for this determinant (Greer, J., T Koerner, R.R. Hardy, K. Hayakawa, and J. Kemp, manuscript in preparation).
These results suggest that most determinants for ATA are carbohydrate structures that can be expressed on glycoproteins, glycoplipids, or possibly on both (42) . In summary, these ATA determinants can be grouped based primarily on 874 Antithymocyte Autoantibody their relatedness to Thy-1 (sensitivity to antiThy-1 blocking, and expression on T lymphoma wild and variant cell lines) and on their distinctive distribution on normal cell types. Further subdivision is possible with respect to sensitivity to periodate treatment and preferential expression in certain mouse strains . In cases where the difference of binding activity by ATA to T lineage cells and cell lines could be considered due to antibody avidity, they are classed in the same group; e.g., in group I-1, levels of staining intensity on the thymus with 1-1139 and 1-4F2 are lower than the others. Y Gene Usage in ATA. The results described above imply that the ATA antigenic determinants could be quite diverse. Diversity of ATA determinants is also suggested by variation in antibody combining sites, as determined by V region gene sequencing of ATA hybridomas. We found that the antibody combining sites of 14 Ly-1 B-derived ATA are encoded by VH genes belonging to four V families 0558, 3609, Q52, Vgam3.8; Table 3 ). Notably, our data revealed that fine specificities definable by our assays correlate with usage of particular V genes, with the exception of 2-2G7 (Q52/A1), whose specificity was not clearly distinguishable from that of another set ofantibodies with the 3609/K combination . Three groups of ATA use nearly identical V genes : group I-1 uses 3609, group I-2 uses a J558 member, and group V uses a different J558 gene. Table 4 shows a summary of further V region sequence data. Two clones of Gr I-2 with identical VD J sequence are derived from a clonal expansion since they have identical VD J sequences . In addition, Southern blots using pJ11 probe (44) reveal the same size Ig H chain rearranged bands, including the presumptive nonproductive alleles (data not shown) . However, Table 4 also demonstrates that the repetitive usage of identical V gene found in ATA is not due to clonal proliferation alone. The four group I-13609 hybridomas are unrelated, as determined by D and JN differences . WG11 and 1-3H5 (in group V) use identical V and JR genes, but are unrelated as distinguished by their D genes . In conclusion, identical V gene usage in ATA hybridomas is due both to clonal expansion and to independent incidence .
Discussion
Numerous studies have demonstrated that carbohydrate structures can serve as differentiation antigens and oncofetal antigens (42, 43) . It becomes increasingly apparent,that antibodies to specific cell types or tumor cells often react with carbohydrate determinants, and several reports of"natural antibodies" reactive with carbohydrate structures are available (42, 43) . Since comparable carbohydrate structures can be expressed on several glycoproteins, glycolipids, or on both, analysis of such specificities often results in obscure data when attempting to ascertain the precise molecular determinants . Another difficulty in the characterization of the target molecules of natural autoantibodies is due to the frequently observed temperature dependence oftheir binding (better at low temperature), suggesting low avidity. Our approach has been to establish monoclonal ATA and examine their reactivity to normal cell types or to chemically modified thymocytes, their crossblocking effect with antiThy-1, and their reactivity to Thy-1 -mutants or Thy-1 gene transfectants . Such analysis has allowed us to conclude that while determinants on thymocytes recognized by natural ATA are diverse, particular specificities predominate, and further, that most of these specificities probably involve carbohydrate structures.
We found that many ATA are specific to determinants as- 875 Hayakawa et al .
sociated with the Thy-1 glycoprotein, which is a heavily glycosylated molecule (30% [wt/vol]) (45) and one of the major glycoproteins present on mouse thymocytes. This also confirms previous data of Thy-l-dependent determinant(s) for ATA that were induced during the production of antiThy-1 polymorphic antibody after allogeneic thymocyte injection (24, 26) . However, while Thy-1 plays a major role, our data also provides several examples of determinants unrelated to Thy-1, and also leaves open the possibility that even the Thy-l-dependent determinants in the thymus might also be expressed on different molecules in other organs or on tumor cells. This may relate to the earlier finding that ATA is detectable in the serum of athymic nude mice (7), and it is interesting to speculate on the relation of some natural ATA to natural anti-tumor cell activity found in sera (6) . Nevertheless, our data suggests that natural autoantibodies specifically recognize fine structures on cell surface molecules that can be altered during differentiation and maturation. Our previous studies of 600 and 3G11 expression on CD4+ T cell subsets provide a clear case of such alteration (31, 46) . Intriguingly, we found that although the ATA defined by thymocyte binding activity show diverse specificities, the B cells that produce such autoantibodies are not randomly distributed among B cell populations; that is, ATA B cells are enriched in a minor B cell subset, Ly-1 B. Our data depend on LPS responsiveness in vitro, and further work willbe necessary to assess the frequency of ATA B cells in unmanipulated cell populations . However, an elevated frequency of ATA B cells in Ly-1 B can be expected since both Ly-1 B cell and conventional B cell fusions generated after LPS culture showed no obvious differences with regard to fusion frequency or production of IgM-secreting wells. Therefore, our results for ATA B cell frequency and ATA secretion lead us to suggest that the ATA naturally found in serum derives solely from Ly-1 B. An increased frequency of the Ly-1 B subset may ac- 
count for high levels of ATA in serum, as has been found for NZB and SM/J mice. The mechanism(s) that results in such a bias ofATAspecific clones in Ly-1 B has not been elucidated. Perhaps key to this question, we found that among various V genes encoding ATA specificities, nearly identical V genes are used in clonally unrelated hybridomas showing similar specificity. One such example, 1-3G11 and 1-3H5, also appears to have identical L chains (sharing an identically size rearranged band with the PECK probe by Southern analysis with several enzymes ; data not shown) . Similar L chain analysis of ATA hybridomas utilizing the 3609 V gene show different sized bands, although their sequences need to be determined to definitely answer the question of L chain usage. Nevertheless, the observation of similar binding specificity with identical V gene usage by clonally unrelated cells suggests that ATA specific B cells were enriched among Ly-1 B cells primarily due to their specificity, likely by an antigen-driven selection mechanism. The origins of such antigens are not clear. However, we presume natural ligands (environmental or auto-antigens) are the most likely candidates for long-term constant selection of such B cells among Ly-1 B, and furthermore, probably lead in part to antibody secretion recognized as spontaneous natural ATA secretion in the serum. We found that clonal proliferation of Ly-1 B cells, as reported elsewhere (16) (17) (18) , also contributes to the higher ATA frequency in Ly-1 B. We speculate that a similar selection mechanism may have been operating even in the event of clonal proliferation, resulting in the increase of ATA B cells specifically, as has been suggested in the generation of Ly-1 + B lymphomas (19) . Therefore, if we expanded our ATA,panel with more Ly-1 B-derived hybridomas, we would likely find that all V genes we have described in this paper would be observed repeatedly.
Close examination of the D region sequence data (Table  4 ) reveals several unusual features in the ATA hybridomas : the arginine (R)-rich sequences of Gr I-13609 V ATA, the short D of Gr I-2, and the apparent D-D fusion of 1-3H5. One possible explanation for the common arginine at the start of the 3609-encoded D segments is that the first two nucleotides may derive from the end of the V segment: in every case the arginine is encoded by a codon that begins with AG. Alternatively, the unique characteristics of arginine may play a role in the binding site of Gr I-1 type ATA antibodies. Unfortunately, the absence ofgermline sequence data precludes any definitive conclusion regarding the origin of this arginine. The short three amino acid residue D sequence in Gr I-2 is reminiscent ofthe three residue D always found with V11-encoded anti-BrMRBC autoantibodies (also derived from Ly-1 B), but numerous examples exist of longer D segments in Ly-1 B-derived autoantibodies, so the significance of such a short D remains equivocal. Finally, the D segment in 1-3H5 appears to be the result of a D-D fusion, a relatively uncommon event in normal rearrangement . It is interesting to note that the most similar antibody, 1-3G11, has a short D (different from 1-3H5) and that every residue found in 1-3G11 is also found in 1-3H5, although arising completely differently. Thus, we might speculate that these four residues could play a role in the selection of ATA activity of the type in Gr V Our data show ATA to be the second autoantibody specificity enriched in the Ly-1 B cell repertoire . We have previously shown another natural antibody, which to BrMRBC, originates almost exclusively from Ly-1 B cells (9, 10) . Compared with antigenic determinants for ATA, those on Br-MRBC are much more restricted: they are recognized by antiBrMRBC autoantibodies that predominantly utilize either a V11 gene together with a V,,9 gene or else a V12 gene together with a V,,4 gene (10, 47). Our recent data by PCR amplification ofDNA from purified B cell populations demonstrates that Ly-1 B overutilize the VH11 gene, as compared with other (conventional) B cells, due to a selection mechanism rather than any restriction of particular V genes to this subpopulation (21) . Reminiscent of anti-BrMRBC antibodies, the finding of repeated usage of the 3609 V gene in the most common ATA specificity is of particular interest, considering its large contribution to the enrichment of ATAspecific B cells in Ly-1 B, whereas members of the 3609 V family have only infrequently been seen in conventional antigen responses. However, our result also suggests that diverse V genes (from several frequently used V families) also characterize the Ly-1 B repertoire established in adult mice. We emphasized here the importance of antigen specificity in contributing to positive selection in the Ly-1 B repertoire, but pose the question as to why such selection preferentially occurs in the Ly-1 B population. This question remains the focus of future investigation .
